Wednesday | june the 3th | 2009
Rotor – Gene 6000: The Next Generation for your Real Time PCR
Main Hall “Marotta” – Italian National Institute of Health
Viale Regina Elena 299 – Roma
- Introduction
Davide De Luca
Explera Sales Agent - Rotor – Gene 6000: The Next Generation for your Real Time PCR
Marino Perini
Diatech Scientific Director
Thursday | may the 14th | 2009
Rotor – Gene 6000: The Next Generation for your Real Time PCR
Department of Biology – Biological Interdepartmental Complex “Vallisneri” – Padua University
Via U. Bassi 58/B – Padua
- Introduction
Chematica
Explera Sales Agency - Rotor – Gene 6000: The Next Generation for your Real Time PCR
Marino Perini
Diatech Scientific Director
Wednesday | april the 22th | 2009
Farmacogenetics: New Opportunities to Personalize the Antitumoral Therapy
Main Hall – Department of Oncological and Surgical Sciences
Padua University
Via Gattamelata 64 – Padua
- Welcome and introduction to the seminary:
Prof. Roberta Bertorelle
Oncological Immunology and Molecular Diagnostcs
Oncological Institute of Veneto – IRCCS - Farmacogenetics: New Opporunities to Personalize the Antitumoral Therapy
Dr. Giuseppe Toffoli
Unity of Clinical Experimental Pharmacogenetics Director
Oncological Reference Center IRCCS - Aviano (PN) - New Pharmacogenetics Tests CE-IVD Based on Pyrosequencing for the Survey of Predictive Genetics Markers in Answer to the Antitumoral Therapyantitumorale
Dr.ss Maura Menghi, Diatech Research & Development
Tuesday | december the 16th | 2008
Farmacogenetics and Antitumoral Therapy
Conference Hall - Oncological Radiotherapy Building - University Hospital OO.RR.
Viale Pinto 1 – Foggia
- Introduction
Dr. Deni Aldo Procaccini
Health Director - University Hospital OO.RR. – Foggia
Dr. Giuseppe Bove - Dr. Sante Romito
Moderators: Dr. Raffaele Antonetti - Dr. Giuseppe Bove - Dr. Sante Romito - K-RAS: Clinical Studies in Development
Dr. Maurizio Di Bisceglie – Foggia - New Pharmacogenetics Tests CE-IVD Based on Pyrosequencing for the Survey of Predictive Genetics Markers in Answer to the Antitumoral Therapy
Dr.ss Maura Menghi,
Diatech Research and Development - Farmacogenetics: New Opportunities to Personalize the Antitumoral Therapy
Dr. Giuseppe Toffoli
Unity of Clinical Experimental Pharmacogenetics Director
Oncological Reference Center IRCCS - Aviano (PN) - Round Table: clue of operative protocols
Prof. P.Bufo – Dr. M.Castriota – Dr. F.Cianci – Dr.ss M.R.d’Agnessa - Dr. M.Di Bisceglie - Dr.ss M. Menghi – Dr.ss M.I.Natalicchio – Dr. V.Nirchio – Dr. G.Toffoli – Dr. F.Tricarico
Thursday | december the 12th | 2008
Rotor – Gene 6000 & Pyrosequencing The Next Generation for your Real Time PCR & Sequencing needs
Hall A – Metaponto Agrobios
S.S. Jonica 106 – Metaponto di Bernalda (MT)
- Introduction
Massimo Cagnazzo
Explera Sales Agent - Rotor – Gene 6000 & Pyrosequencing The Next Generation for your Real Time PCR & Sequencing needs
Marino Perini
Direttore scientifico - Diatech
friday | december the 5th | 2008
Farmacogenetics: New Opporunities to Personalize the Antitumoral Therapy
Hall B and C – Conference Center “Bastianelli” - Regina Elena InstituteVia Ognibene 23 – Rome
- Welcome and introduction to the seminary
Prof. Paola Muti
Scientific Director - Regina Elena Institute - Farmacogenetics: New Opportunities to Personalize the Antitumoral Therapy
Dr. Giuseppe Toffoli
Unity of Clinical Experimental Pharmacogenetics Director
Oncological Reference Center IRCCS - Aviano (PN) - New Pharmacogenetics Tests CE-IVD Based on Pyrosequencing for the Survey of Predictive Genetics Markers in Answer to the Antitumoral Therapy
Dott.ssa Maura Menghi, Diatech Research and Development
Thursday | october the 30th | 2008
The Epigenetics and new Approaches for Methylation Analysis
Royal Continental Hotel
Via Partenope 38/44 – Naples
- Welcome and introduction to the seminary
Fabio Biondi
Explera Administration Council President - Epigenetics: the reading key of DNA
Raffaele Teperino
IEOS CNR - New Approaches for Methylation Analysis: High Resolution Melt and Pyrosequencing
Marino Perini
Diatech Scientific Director